BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6299050)

  • 1. Plasma FSH, LH and prolactin levels in postmenopausal women undergoing cyclofenil treatment.
    Nencioni T; Miragoli A; Bertaglia MG; Parini J
    Acta Obstet Gynecol Scand; 1982; 61(6):487-90. PubMed ID: 6299050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of cyclofenil in menopausal women.
    Schubert L; Sansa G; Nencioni T; Polvani F; Pruneri C; Sostero M; Peruzy AD; De Santis AM
    Acta Eur Fertil; 1977 Mar; 8(1):83-110. PubMed ID: 868455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of lactation by cyclofenil and bromocriptine.
    Thorbert G; Akerlund M
    Br J Obstet Gynaecol; 1983 Aug; 90(8):739-42. PubMed ID: 6411113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Value of cyclofenil in the inhibition of lactation. Efficacy compared to bromocriptine].
    Cingotti M; Magnin G
    Rev Fr Gynecol Obstet; 1986; 81(6-7):369-72. PubMed ID: 3094130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bromocryptine-cyclofenil associated therapy: an effective and safe mode of treatment of female normoprolactinemic infertility.
    Moggi G; Giampietro O; De Luca Brunori I
    Acta Eur Fertil; 1983; 14(5):319-25. PubMed ID: 6424373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of cyclofenil on atypical functional patterns of the hypothalamo-hypophyseo-thyroid axis encountered in postmenopausal women].
    Custro N; Scaffidi V; Patanella I
    Minerva Endocrinol; 1984; 9(1):37-45. PubMed ID: 6438465
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of morphine on the hypothalamic-pituitary axis in postmenopausal women.
    Hemmings R; Fox G; Tolis G
    Fertil Steril; 1982 Mar; 37(3):389-91. PubMed ID: 6800848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of low dose oestrogen on circulating prolactin. LH and FSH levels in post-menopausal women.
    Robyn C; Vekemans M
    Acta Endocrinol (Copenh); 1976 Sep; 83(1):9-14. PubMed ID: 989226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.
    Reyes FI; Winter JS; Faiman C
    Am J Obstet Gynecol; 1977 Nov; 129(5):557-64. PubMed ID: 910845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocrinological features and endometrial morphology in climacteric women receiving hormone replacement therapy.
    Grasso A; Baraghini F; Barbieri C; Dalla Vecchia E; Previdi AM; Di Renzo GC; Volpe A
    Maturitas; 1982 Apr; 4(1):19-26. PubMed ID: 6285153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different dopaminergic control of plasma luteinizing hormone, follicle-stimulating hormone and prolactin in ovulatory and postmenopausal women: effect of ovariectomy.
    De Leo V; Petraglia F; Bruno MG; Lanzetta D; Inaudi P; D'Antona N
    Gynecol Obstet Invest; 1989; 27(2):94-8. PubMed ID: 2499519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of cyclofenil on hormonal dynamics, follicular development and cervical mucus in normal and oligomenorrhoeic women.
    Yong EL; Glasier A; Hillier H; Ledger W; Caird L; Beattie G; Sweeting V; Thong J; Baird DT
    Hum Reprod; 1992 Jan; 7(1):39-43. PubMed ID: 1551955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of oestrogens and hours of sleep on cortisol, FSH, LH, and prolactin in hypogonadal women.
    Schiff I; Regestein Q; Schinfeld J; Ryan KJ
    Maturitas; 1980 Oct; 2(3):179-83. PubMed ID: 6777633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation between plasma hormone profiles, symptoms, and response to oestrogen treatment in women approaching the menopause.
    Chakravarti S; Collins WP; Thom MH; Studd JW
    Br Med J; 1979 Apr; 1(6169):983-5. PubMed ID: 219937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of veralipride on LH, FSH, and PRL levels and on the climacteric syndrome].
    De Cecco L; Venturini PL; Alibrandi MP; Grondona AL; Morano S; Penna L; Campanella G; Ragni N
    Rev Fr Gynecol Obstet; 1985 Feb; 80(3):152-5. PubMed ID: 3922034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of raloxifene, one of the selective estrogen receptor modulators, on pituitary-ovary axis and prolactin in postmenopausal women.
    Cheng WC; Yen ML; Hsu SH; Chen KH; Tsai KS
    Endocrine; 2004; 23(2-3):215-8. PubMed ID: 15146102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum prolactin levels during inhibition of lactation by cyclofenil.
    Polati F; Pesando P; Nava C; Zara C
    Clin Exp Obstet Gynecol; 1980; 7(2):131-4. PubMed ID: 7249350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclophenil, a non-steroidal compound with a higher central than peripheral oestrogenic activity: study of its effects on uterine growth and on some central parameters in castrated female rats.
    Celotti F; Avogadri N; Melcangi RC; Milani S; Negri-Cesi P
    Acta Endocrinol (Copenh); 1984 Nov; 107(3):340-5. PubMed ID: 6438973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of conjugated oestrogens on circulating oestradiol, oestrone, LH, FSH and prolactin levels in postmenopausal women.
    Luisi M; Franchi F; Argenio GF; Barletta D; Romano MR; Bernini GP; Gasperi M; Sgrilli R
    Int J Tissue React; 1981 Jun; 3(2):77-81. PubMed ID: 6799393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of prolactin in the menopause.
    Metka M; Holzer G; Raimann H; Heytmanek G; Hartmann B; Kurz C
    Maturitas; 1994 Dec; 20(2-3):151-4. PubMed ID: 7715467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.